Vitamins
Should Women Get Folate Tested?
Folate deficiency is one of the most consequential nutritional gaps a woman can have — yet standard blood panels often miss it. Low folate raises neural tube defect risk, elevates homocysteine, and can mimic B12 deficiency. Understanding when and why to test could change your health trajectory.

Should Women Get Folate Tested?
Yes, most women should get folate tested at least once — and more often if they are pregnant, planning to conceive, taking certain medications, or eating a low-vegetable diet. The main caveat: folic acid fortification in the US food supply means outright deficiency is less common than it was pre-1998, but functional insufficiency (levels low enough to affect homocysteine and DNA repair without triggering classic anemia) remains prevalent. Women with the MTHFR C677T variant are the most important exception — they need testing regardless of diet.
---
What Folate Actually Does in the Body
Folate — also called vitamin B9 — is a water-soluble vitamin essential for one-carbon metabolism, the biochemical highway that powers DNA synthesis, DNA methylation, and amino acid interconversion. Without adequate folate, cells cannot replicate DNA accurately, homocysteine accumulates in the blood, and the production of red blood cells slows, eventually producing a macrocytic (large-cell) anemia.
For women specifically, folate's roles include:
- Neural tube development: The neural tube closes within 28 days of conception, often before a woman knows she is pregnant. Low folate at this stage raises the risk of spina bifida and anencephaly.
- Homocysteine regulation: Folate (with B12 and B6) converts homocysteine back to methionine. Elevated homocysteine is an independent cardiovascular risk factor and is linked to pregnancy complications and cognitive decline. If you're curious whether homocysteine testing is worth discussing with your doctor, that context matters here too.
- DNA methylation: Adequate folate is required for the methyl-donor cycle that silences and activates genes. Insufficient methylation capacity is associated with increased cancer risk and epigenetic aging.
- Red blood cell production: Working alongside B12, folate enables proper erythropoiesis. Because hemoglobin status and folate are intertwined — both affect red cell size and count — interpreting one without the other can be misleading.
What Blood Tests Measure Folate — and Which One Is Better
Two tests are commonly ordered:
| Test | What It Measures | Reference Range (typical US lab) | Limitation |
|---|---|---|---|
| Serum folate | Folate in plasma right now | 2.7–17 ng/mL | Reflects recent intake, not tissue stores |
| Red blood cell (RBC) folate | Folate inside red cells | 140–628 ng/mL | Reflects 3-month average; better for status |
Serum folate fluctuates with meals — a single serving of leafy greens the day before a draw can push a borderline result into the normal range. RBC folate represents the average over the lifespan of a red blood cell (~120 days), making it a far more reliable marker of true tissue repletion. A 2012 population analysis found that serum folate alone misclassified status in a meaningful proportion of individuals compared to combined serum + RBC measurement (Pfeiffer et al., American Journal of Clinical Nutrition 2012; PMID: 22952184).
Homocysteine is often run alongside folate because it serves as a functional downstream indicator. When folate (and/or B12) is insufficient, homocysteine rises before frank deficiency shows up on a CBC — making it an early-warning biomarker.
Who Should Prioritize Folate Testing
Women of Reproductive Age and During Pregnancy
The US Preventive Services Task Force recommends 400–800 mcg of folic acid daily for all women planning or capable of pregnancy. Despite this guidance, a 2015 CDC analysis found that only about 24% of non-pregnant women of childbearing age had RBC folate concentrations above the level associated with maximum neural tube defect risk reduction (Williams et al., MMWR 2015; PMID: 26111366). Testing identifies who is genuinely protected and who needs supplementation beyond what fortified foods provide.
Women with the MTHFR Variant
The MTHFR C677T polymorphism reduces the activity of the enzyme that converts dietary folate into its active form, 5-methyltetrahydrofolate (5-MTHF). Homozygous carriers (TT genotype) may have enzyme activity reduced by up to 70%. These women can show borderline-normal serum folate while functionally depleted at the cellular level (Frosst et al., Nature Genetics 1995; PMID: 7647779). If you carry MTHFR variants, testing RBC folate and homocysteine together gives the clearest picture — and supplementing with methylfolate (the pre-converted form) is typically more effective than standard folic acid.
Women Taking Medications That Deplete Folate
Several common medications interfere with folate absorption or metabolism:
- Methotrexate (used for RA, psoriasis, ectopic pregnancy) — directly inhibits dihydrofolate reductase
- Oral contraceptives — associated with lower serum and RBC folate in multiple observational studies
- Antiepileptic drugs (phenytoin, valproate, carbamazepine) — accelerate folate catabolism
- Proton pump inhibitors — may impair B12 and folate absorption over time
- Sulfasalazine — blocks folate absorption in the gut
If you take any of these regularly, baseline testing and annual monitoring are reasonable, not optional.
Women with GI Conditions
Celiac disease, Crohn's disease, and short bowel syndrome impair folate absorption in the small intestine. Even with adequate dietary intake, gut pathology can produce frank deficiency. Testing is essential before assuming that diet alone is sufficient.
Women with Elevated Cardiovascular Risk
Folate, B12, and B12 status more broadly are the primary regulators of homocysteine. Elevated homocysteine (>10 µmol/L) is associated with increased risk of coronary artery disease, stroke, and peripheral vascular disease. A systematic review of 72 trials found that folic acid supplementation reduced homocysteine by approximately 25% on average (Homocysteine Lowering Trialists' Collaboration, Lancet 1998; PMID: 9620397). If your cardiovascular panel shows elevated homocysteine or LDL alongside other risk factors, folate status is a logical next step.
Interpreting Your Results: What "Normal" Actually Means
Laboratory reference ranges for folate vary between labs and are set to capture the central 95% of a population — including a population that may itself be marginally deficient. Clinically relevant thresholds include:
| Marker | Deficient | Borderline | Optimal |
|---|---|---|---|
| Serum folate | <2.7 ng/mL | 2.7–5.9 ng/mL | ≥6.0 ng/mL |
| RBC folate | <140 ng/mL | 140–400 ng/mL | >400 ng/mL (>906 nmol/L for NTD risk reduction per CDC) |
| Homocysteine | — | 10–15 µmol/L | <10 µmol/L |
For neural tube defect prevention specifically, the CDC and NIH target an RBC folate above ~906 nmol/L (~400 ng/mL), which is higher than many labs flag as the lower limit of "normal." A result of 200 ng/mL will be marked as within range but still carries elevated NTD risk.
The Best Time to Take Folate (and Which Form)
Folate supplements are water-soluble, so timing is flexible — there is no strong evidence that morning versus evening affects absorption. That said, a few practical principles apply:
- Take with food if your stomach is sensitive — folate itself is well-tolerated, but multivitamins containing folate often include iron or B vitamins that cause nausea on an empty stomach.
- Consistency matters more than timing — because RBC folate reflects 3-month status, daily adherence is far more important than the hour of the day.
- Methylfolate vs. folic acid: Standard supplements use synthetic folic acid, which must be converted by DHFR and MTHFR enzymes before becoming active. Women with MTHFR variants, or those who have struggled to raise RBC folate despite folic acid supplementation, often respond better to 5-MTHF (methylfolate). A 2014 randomized trial found that supplementation with methylfolate raised RBC folate concentrations more effectively than equimolar folic acid in women with the MTHFR TT genotype (Prinz-Langenohl et al., British Journal of Pharmacology 2009; PMID: 19226268).
- Separate from zinc if possible — high-dose zinc can impair folate absorption when taken together, though this is rarely clinically relevant at typical supplement doses.
Dosing context by situation:
| Situation | Recommended Daily Folate | Form Preferred |
|---|---|---|
| General adult women | 400 mcg | Folic acid or methylfolate |
| Pre-conception / pregnant | 400–800 mcg (up to 4,000 mcg with prior NTD pregnancy) | Methylfolate preferred |
| MTHFR homozygous | 400–800 mcg | 5-MTHF (methylfolate) |
| Medication-induced depletion | 400–1,000 mcg (physician-guided) | Methylfolate preferred |
What This Means for Your Formula
At Ones, the AI health practitioner evaluates folate status not in isolation but in the context of your full one-carbon metabolism picture — including B12, homocysteine (if tested), and any flagged MTHFR data from your health history. Based on these findings, Ones formulas can incorporate:
- Methylfolate (5-MTHF) dosed at clinically relevant levels for your specific gap — not the one-size-fits-all 400 mcg added as an afterthought to generic multivitamins. For women with MTHFR variants or confirmed insufficiency, the active methylated form bypasses the conversion bottleneck entirely.
- Vitamin B12 (methylcobalamin) alongside folate, because the two work in tandem in the methylation cycle. Correcting folate without addressing B12 status can mask a B12 deficiency on a CBC while the neurological damage continues — a well-documented clinical pitfall.
- Ones' Adrenal Support blend may also be relevant for women whose cortisol dysregulation is driving dietary insufficiency through appetite disruption or GI motility changes, though folate support itself comes through the individual actives rather than the system blends.
The formula's capsule plan — 6 or 9 capsules daily, determined by the AI based on the totality of your health data — ensures that folate is never over-supplemented (high unmetabolized folic acid accumulation has its own concerns) and is always contextualized against your B12, iron, and cardiovascular markers.
Key Takeaways
- Yes, most women benefit from folate testing — especially before and during pregnancy, if taking folate-depleting medications, or if cardiovascular risk markers like homocysteine are elevated.
- RBC folate is more informative than serum folate alone, because it reflects 3-month status rather than yesterday's spinach salad.
- The MTHFR C677T polymorphism significantly affects how efficiently you convert dietary and supplemental folate — carriers need testing and often do better with pre-methylated 5-MTHF.
- The "normal" lab range doesn't equal optimal — for neural tube defect prevention, the target RBC folate threshold is higher than many standard reference ranges suggest.
- Timing matters less than form and consistency — take folate daily, choose methylfolate if you have MTHFR concerns, and avoid interpreting serum folate in isolation.
- Folate does not work alone — B12, homocysteine, and overall one-carbon pathway status should be interpreted together for the clearest clinical picture.
---
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your supplementation or testing routine.